GH Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Guardant Health Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 17.35 USD 1.11%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast GH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GH is 39.84 USD with a low forecast of 27.27 USD and a high forecast of 56.7 USD.

GH Lowest Forecast

Wall Street Target

GH Average Forecast

Wall Street Target

GH Highest Forecast

Wall Street Target

57% Upside

130% Upside

227% Upside

The latest public price target was made on Apr 24, 2024 by Chase Knickerbocker from Craig-Hallum , who expects GH stock to rise by 61% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Chase Knickerbocker Craig-Hallum	28 USD Upside 61%	3 days ago Apr 24, 2024	Craig-Hallum Assumes Guardant Health (GH) at Buy, 'We think that GH is undervalued' StreetInsider
David Westenberg Piper Sandler	40 USD Upside 131%	7 months ago Sep 27, 2023	Guardant Health Has 'Underlying Business Strength' Says This Bullish Analyst Benzinga
Unknown Analyst Goldman Sachs	45 USD Upside 159%	1 year ago Feb 6, 2023	Goldman Sachs Maintains Buy on Guardant Health, Lowers Price Target to $45 Benzinga

Price Target	28 USD
Upside/Downside	61%

Price Target	40 USD
Upside/Downside	131%

Price Target	45 USD
Upside/Downside	159%

Topchoice Medical Co Inc

60% Upside

Nanjing Xinjiekou Department Store Co Ltd

47% Upside

Option Care Health Inc

36% Upside

MCI Onehealth Technologies Inc

47% Upside

Topchoice Medical Co Inc

60% Upside

Nanjing Xinjiekou Department Store Co Ltd

47% Upside

Option Care Health Inc

36% Upside

MCI Onehealth Technologies Inc

47% Upside

Talkspace Inc

31% Upside

Amedisys Inc

9% Upside

Kooth PLC

101% Upside

Healthia Ltd

0% Upside

Revenue
Forecast

For the last 6 years the compound annual growth rate for Guardant Health Inc's revenue is 50%. The projected CAGR for the next 3 years is 22%.

50%

22%

-1%

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

-1%

What are analyst estimates?

Net Income
Forecast

N/A

N/A

-20%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for GH is 39.84 USD with a low forecast of 27.27 USD and a high forecast of 56.7 USD.

For the last 6 years the compound annual growth rate for Guardant Health Inc's revenue is 50%. The projected CAGR for the next 3 years is 22%.

Join more than 131,800+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.